EPISODE · Feb 10, 2025 · 11 MIN
What is the biggest hurdle in drug repurposing today?—with Mika Newton
from AI and Healthcare · host xCures
Drug repurposing offers a way to find new treatments using existing medications, but regulatory hurdles and financial disincentives often prevent progress. Mika Newton and Bob Battista examine the challenges of data sharing in the pharmaceutical industry, the high costs of clinical trials, and why companies hesitate to pursue niche indications. They also explore potential policy solutions that could encourage collaboration and make more life-saving treatments accessible to patients.
What this episode covers
Drug repurposing offers a way to find new treatments using existing medications, but regulatory hurdles and financial disincentives often prevent progress. Mika Newton and Bob Battista examine the challenges of data sharing in the pharmaceutical industry, the high costs of clinical trials, and why companies hesitate to pursue niche indications. They also explore potential policy solutions that could encourage collaboration and make more life-saving treatments accessible to patients.
NOW PLAYING
What is the biggest hurdle in drug repurposing today?—with Mika Newton
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m